The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Control of Endemic Methicillin-Resistant Staphylococcus aureus: A Cost-Benefit Analysis in an Intensive Care Unit
Abstract
CONTEXT: Despite the success of some countries in controlling endemic methicillin-resistant Staphylococcus aureus (MRSA), such programs have not been implemented for some hospitals with endemic infection because of concerns that these programs would be costly and of limited benefit. OBJECTIVE: To compare the costs and benefits of an MRSA control program in an endemic setting. DESIGN AND SETTING: Case-control study conducted at a medical intensive care unit (ICU) of a French university hospital with a 4% prevalence of MRSA carriage at ICU admission. PATIENTS: Twenty-seven randomly selected patients who had ICU-acquired MRSA infection between January 1993 and June 1997, matched to 27 controls hospitalized during the same period without MRSA infection. MAIN OUTCOME MEASURES: Intensive care unit costs attributable to MRSA infection, computed from excess therapeutic intensity in cases using estimates from a cost model derived in the same ICU, were compared with costs of the control program, derived from time-motion study of nurses and physicians. The threshold for MRSA carriage that would make the control strategy dominant was determined; sensitivity analyses varied rates of MRSA transmission and ratio of infection to transmission, length of ICU stay, and costs of isolation precautions. RESULTS: The mean cost attributable to MRSA infection was US $9275 (median, $5885; interquartile range, $1400-$16,720). Total costs of the control program ranged from $340 to $1480 per patient. A 14% reduction in MRSA infection rate resulted in the control program being beneficial. In sensitivity analyses, the control strategy was dominant for a prevalence of MRSA carriage on ICU admission ranging from 1% to 7%, depending on costs of control measures and MRSA transmission, for infection rates greater than 50% following transmission. CONCLUSIONS: In this example of a hospital with endemic MRSA infection, selective screening and isolation of carriers on ICU admission are beneficial compared with no isolation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Methicillin-Resistant Staphylococcus aureus
Brumfitt, W., & Hamilton-Miller, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201806 · Cited by 934
Methicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Epidemiology of Nosocomial Infections Caused by Methicillin-Resistant Staphylococcus aureus
THOMPSON, R. L., CABEZUDO, I., & WENZEL, R. P. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-309 · Cited by 651
Nine equivalents of nursing manpower use score (NEMS)
Miranda, D. R., Moreno, R., & Iapichino, G. (1997) · Intensive Care Medicine · doi:10.1007/s001340050406 · Cited by 382
The Progressive Intercontinental Spread of Methicillin-Resistant Staphylococcus aureus
Ayliffe, G. A. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s74 · Cited by 375
Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureus
Romero-Vivas, J., Rubio, M., Fernandez, C., & Picazo, J. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1417 · Cited by 318
Jernigan, J. A., Titus, M. G., Groschel, D. H. M., Getchell-White, S. I., & Farr, B. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008770 · Cited by 317
Recommendations for Preventing the Spread of Vancomycin Resistance
(1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30140952 · Cited by 281
Harbarth, S., Rutschmann, O., Sudre, P., & Pittet, D. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.2.182 · Cited by 267
Haley, R. W., Cushion, N. B., Tenover, F. C., Bannerman, T. L., Dryer, D., Ross, J., Sanchez, P. J., & Siegel, J. D. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.3.614 · Cited by 262
Economic evaluation and health care. What does it mean?
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6905.670 · Cited by 249
Girou, E., Pujade, G., Legrand, P., Cizeau, F., & Brun‐Buisson, C. (1998) · Clinical Infectious Diseases · doi:10.1086/514695 · Cited by 210
Self-citationControl of Methicillin-Resistant Staphylococcus aureus at a University Hospital: One Decade Later
Jernigan, J. A., Clemence, M. A., Stott, G. A., Titus, M. G., Alexander, C. H., Palumbo, C. M., & Farr, B. M. (1995) · Infection Control & Hospital Epidemiology · doi:10.1086/647042 · Cited by 194
Aubry-Damon, H., Legrand, P., Brun‐Buisson, C., Astier, A., Soussy, C., & Leclercq, R. (1997) · Clinical Infectious Diseases · doi:10.1086/513749 · Cited by 80
Self-citationStamm, A. M., Long, M. N., & Belcher, B. (1993) · American Journal of Infection Control · doi:10.1016/0196-6553(93)90227-u · Cited by 80
Nosocomial staphylococcal outbreaks.
Emmerson, M. (1994) · PubMed · Cited by 33
A Model to Compute the Medical Cost of Patients in Intensive Care
Chaix, C., Durand‐Zaleski, I., Alberti, C., & Brun‐Buisson, C. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915060-00005 · Cited by 33
Self-citation
Cited by
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Grundmann, H., Aires-de-Sousa, M., Boyce, J., & Tiemersma, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68853-3 · Cited by 1,101
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Davis, K. A., Stewart, J. J., Crouch, H. K., Florez, C. E., & Hospenthal, D. R. (2004) · Clinical Infectious Diseases · doi:10.1086/422997 · Cited by 611
Metadata
- Authors
- Chaix, C., Durand-Zaleski, I., Alberti, C., & Brun-Buisson, C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-11-10
- Volume
- 282
- Issue
- 18
- Pages
- 1745
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2000361908
- Cited by
- 339
- References
- 19
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.